TY - JOUR
T1 - Chlamydia-secreted protease CPAF degrades host antimicrobial peptides
AU - Tang, Lingli
AU - Chen, Jianlin
AU - Zhou, Zhiguang
AU - Yu, Ping
AU - Yang, Zhangsheng
AU - Zhong, Guangming
N1 - Publisher Copyright:
© 2015 Institut Pasteur.
PY - 2015
Y1 - 2015
N2 - Chlamydia trachomatis infection in the lower genital tract, if untreated, can ascend to the upper genital tract, potentially leading to complications such as tubal factor infertility. The ascension involves cell-to-cell spreading, which may require C. trachomatis organisms to overcome mucosal extracellular effectors such as antimicrobial peptides. We found that among the 8 antimicrobial peptides tested, the cathelicidin LL-37 that is produced by both urogenital epithelial cells and the recruited neutrophils possessed a most potent antichlamydial activity. Interestingly, this antichlamydial activity was completely inhibited by CPAF, a C. trachomatis-secreted serine protease. The inhibition was dependent on CPAF's proteolytic activity. CPAF selectively degraded LL-37 and other antimicrobial peptides with an antichlamydial activity. CPAF is known to secrete into and accumulate in the infected host cell cytoplasm at the late stage of chlamydial intracellular growth and may be released to confront the extracellular antimicrobial peptides before the intra-inclusion organisms are exposed to extracellular environments during host cell lysis and chlamydial spreading. Thus, the finding that CPAF selectively targets host antimicrobial peptides that possess antichlamydial activities for proteolysis suggests that CPAF may contribute to C. trachomatis pathogenicity by aiding in ascending infection.
AB - Chlamydia trachomatis infection in the lower genital tract, if untreated, can ascend to the upper genital tract, potentially leading to complications such as tubal factor infertility. The ascension involves cell-to-cell spreading, which may require C. trachomatis organisms to overcome mucosal extracellular effectors such as antimicrobial peptides. We found that among the 8 antimicrobial peptides tested, the cathelicidin LL-37 that is produced by both urogenital epithelial cells and the recruited neutrophils possessed a most potent antichlamydial activity. Interestingly, this antichlamydial activity was completely inhibited by CPAF, a C. trachomatis-secreted serine protease. The inhibition was dependent on CPAF's proteolytic activity. CPAF selectively degraded LL-37 and other antimicrobial peptides with an antichlamydial activity. CPAF is known to secrete into and accumulate in the infected host cell cytoplasm at the late stage of chlamydial intracellular growth and may be released to confront the extracellular antimicrobial peptides before the intra-inclusion organisms are exposed to extracellular environments during host cell lysis and chlamydial spreading. Thus, the finding that CPAF selectively targets host antimicrobial peptides that possess antichlamydial activities for proteolysis suggests that CPAF may contribute to C. trachomatis pathogenicity by aiding in ascending infection.
KW - CPAF
KW - Chlamydia trachomatis
KW - Proteolysis of antimicrobial peptides
UR - http://www.scopus.com/inward/record.url?scp=84942907216&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84942907216&partnerID=8YFLogxK
U2 - 10.1016/j.micinf.2015.02.005
DO - 10.1016/j.micinf.2015.02.005
M3 - Article
C2 - 25752416
AN - SCOPUS:84942907216
SN - 1286-4579
VL - 17
SP - 402
EP - 408
JO - Microbes and Infection
JF - Microbes and Infection
IS - 6
ER -